In contrast, further investigation into age, pathological grades, and tumor stages highlighted a clear pattern of differential CD276 expression; CD276 levels were notably higher in older patients, suggesting a potential age-related increase in expression (Figure 2B, p<0.05). Here, CD276 is linked to neoplasm.